FDA clears Phasix ST Umbilical Hernia Patch, marking its commercial launch for effective hernia treatment.
NICE recommends Joenja for treating APDS, offering new hope for patients with this rare immune disorder.
Ivonescimab + chemotherapy show strong Phase III results for first-line treatment of advanced squamous NSCLC.